Erythema nodosum as a cutaneous manifestation of COVID-19 infection

BMJ Case Rep. 2020 Jul 8;13(7):e236613. doi: 10.1136/bcr-2020-236613.

Abstract

Erythema nodosum (EN) is a common dermatological manifestation with many different aetiologies. Often however, the aetiology remains unidentified. We present here a 42-year-old male patient with an EN that is due to an acute COVID-19 infection. Most of the usual aetiologies were excluded by laboratory testing and imaging studies. This case is, to our knowledge, the first report of this cutaneous manifestation in the context of a COVID-19 infection. The EN was successfully treated with the disappearance of the COVID-19 infection and topical corticosteroids.

Keywords: TB and other respiratory infections; dermatology.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Analgesics / administration & dosage*
  • Betacoronavirus / isolation & purification
  • COVID-19
  • COVID-19 Testing
  • Clinical Laboratory Techniques / methods
  • Coronavirus Infections* / complications
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / physiopathology
  • Diagnosis, Differential
  • Erythema Nodosum* / diagnosis
  • Erythema Nodosum* / etiology
  • Erythema Nodosum* / therapy
  • Glucocorticoids / administration & dosage*
  • Humans
  • Male
  • Pandemics*
  • Pneumonia, Viral* / complications
  • Pneumonia, Viral* / diagnosis
  • Pneumonia, Viral* / physiopathology
  • Radiography, Thoracic / methods
  • SARS-CoV-2
  • Skin Cream / administration & dosage
  • Tomography, X-Ray Computed / methods*
  • Treatment Outcome

Substances

  • Analgesics
  • Glucocorticoids